ES2056838T3 - Agente para la regulacion del apetito o un agente hipnotico. - Google Patents

Agente para la regulacion del apetito o un agente hipnotico.

Info

Publication number
ES2056838T3
ES2056838T3 ES87850349T ES87850349T ES2056838T3 ES 2056838 T3 ES2056838 T3 ES 2056838T3 ES 87850349 T ES87850349 T ES 87850349T ES 87850349 T ES87850349 T ES 87850349T ES 2056838 T3 ES2056838 T3 ES 2056838T3
Authority
ES
Spain
Prior art keywords
agent
appetite
regulation
hypnotic
pro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87850349T
Other languages
English (en)
Inventor
Charlotte Erlanson-Albertsson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8604953A external-priority patent/SE8604953D0/xx
Priority claimed from SE8702274A external-priority patent/SE8702274D0/xx
Application filed by Draco AB filed Critical Draco AB
Application granted granted Critical
Publication of ES2056838T3 publication Critical patent/ES2056838T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN AGENTE PARA LA REGULACION DEL APETITO O UN AGENTE PARA DORMIR, QUE CONSTA DEL PEPTIDO DE ACTIVACION EN PROCOLIPASA, QUE CONSTA DE LA SECUENCIA PEPTIDICA X - PRO - Y - PRO - ARG, EN LA QUE A) X ES ALA E Y ES GLY O B) X ES VAL E Y ES ASP, O UNO DE SUS DERIVADOS.
ES87850349T 1986-11-20 1987-11-13 Agente para la regulacion del apetito o un agente hipnotico. Expired - Lifetime ES2056838T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8604953A SE8604953D0 (sv) 1986-11-20 1986-11-20 Aptitreglerande medel eller somnmedel
SE8702274A SE8702274D0 (sv) 1987-06-01 1987-06-01 Aptitreglerande medel eller somnmedel ii

Publications (1)

Publication Number Publication Date
ES2056838T3 true ES2056838T3 (es) 1994-10-16

Family

ID=26659581

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87850349T Expired - Lifetime ES2056838T3 (es) 1986-11-20 1987-11-13 Agente para la regulacion del apetito o un agente hipnotico.

Country Status (13)

Country Link
US (1) US5494894A (es)
EP (1) EP0269595B1 (es)
JP (1) JP2575159B2 (es)
AU (1) AU608783B2 (es)
CA (1) CA1302878C (es)
DE (1) DE3786530T2 (es)
DK (1) DK583687A (es)
ES (1) ES2056838T3 (es)
FI (1) FI875129A (es)
IE (1) IE60452B1 (es)
NO (1) NO874691L (es)
NZ (1) NZ222480A (es)
PH (1) PH25586A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64356B1 (en) * 1986-07-28 1995-07-26 Bioscience Int Inc Diagnosis severity prediction and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens
DK583687A (da) * 1986-11-20 1988-05-21 Draco Ab Middel til regulering af appetit eller sovemiddel
SE9100284D0 (sv) * 1991-01-30 1991-01-30 Astra Ab Novel peptide
US6686444B2 (en) 1996-08-22 2004-02-03 Children's Medical Center Corporation Osteopontin derived chemotactic peptides and methods of use
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
US6180494B1 (en) * 1999-03-11 2001-01-30 Micron Technology, Inc. Integrated circuitry, methods of fabricating integrated circuitry, methods of forming local interconnects, and methods of forming conductive lines
SE0302253D0 (sv) * 2003-08-21 2003-08-21 Forskarpatent I Syd Ab Lipase-colipase inhibitor
WO2007070563A2 (en) * 2005-12-13 2007-06-21 Harkness Pharmaceuticals, Inc. Stable solid forms of enterostatin
EP1973558A4 (en) * 2005-12-13 2009-12-23 Harkness Pharmaceuticals Inc METHODS OF TREATING OBESITY WITH ENTEROSTATIN
US20070149442A1 (en) * 2005-12-13 2007-06-28 Byron Rubin Non-hygroscopic compositions of enterostatin
AU2007272954A1 (en) * 2006-07-11 2008-01-17 Harkness Pharmaceuticals, Inc. Methods of treating obesity using satiety factors
WO2009033815A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of the peptide combination ala-pro-gly-pro-arg with cecropin a as a therapeutic agent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
US4948723A (en) * 1987-01-16 1990-08-14 Bioscience International, Inc. Method of diagnosis and severity-assessment of pancreatic disease
IE64356B1 (en) * 1986-07-28 1995-07-26 Bioscience Int Inc Diagnosis severity prediction and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens
DK583687A (da) * 1986-11-20 1988-05-21 Draco Ab Middel til regulering af appetit eller sovemiddel

Also Published As

Publication number Publication date
NZ222480A (en) 1991-07-26
NO874691L (no) 1988-05-24
CA1302878C (en) 1992-06-09
EP0269595B1 (en) 1993-07-14
AU8091487A (en) 1988-05-26
AU608783B2 (en) 1991-04-18
DE3786530T2 (de) 1993-10-28
EP0269595A3 (en) 1990-06-13
FI875129A (fi) 1988-05-21
JP2575159B2 (ja) 1997-01-22
US5494894A (en) 1996-02-27
DK583687D0 (da) 1987-11-06
IE873124L (en) 1988-05-20
NO874691D0 (no) 1987-11-11
DE3786530D1 (de) 1993-08-19
EP0269595A2 (en) 1988-06-01
FI875129A0 (fi) 1987-11-19
DK583687A (da) 1988-05-21
PH25586A (en) 1991-08-08
JPS63211235A (ja) 1988-09-02
IE60452B1 (en) 1994-07-13

Similar Documents

Publication Publication Date Title
ES2056838T3 (es) Agente para la regulacion del apetito o un agente hipnotico.
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
DE68910713T2 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
ES2115896T3 (es) Composicion cosmetica que contiene como agente reductor un n-mercapto-alquil alcandiamida o una de sus sales cosmeticamente aceptable.
MX9302917A (es) Derivados de proteinas c humanas, procedimiento para su preparacion y formulacion famaceutica que los contiene.
DE69832158D1 (de) Isolierung und strukturelle aufklärung der kryostatischen linearen und cyclo-depsipeptide dolastatin 16, dolastatin 17, und dolastatin 18
DK289285D0 (da) Thymopentin analoge
ES1005875Y (es) Pinza para el cabello
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
ES2044963T3 (es) Procedimiento para el tratamiento de gases industriales que contiene compuestos de azufre.
NO925041L (no) Nye 2-sakkarinylmetylaryl- og -aryloksyacetater som er nyttige som inhibitorer for proteolytiske enzymer samt preparater og anvendelse derav
ES2110628T3 (es) Catalizador vehiculante y su uso.
ES2176639T3 (es) Utilizacion de al menos un derivado de 3-oxido de pirimidina sustituido en la posicion 6 para favorecer la estimulacion de la tirosinasa.
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
DE3780047D1 (de) Verwendung biologisch aktiver polypeptide und diese enthaltende zusammensetzungen.
DE69024400T2 (de) Dem menschlichen Calpastatin ähnliches Polypeptid
DE3886517T2 (de) Menschlicher Prourokinase ähnliches Polypeptid.
ES2162427T3 (es) Diluyente de esperma que comprende fosfocaseinato natural o beta-lactoglobulina, su procedimiento de preparacion y sus utilizaciones.
IT1231495B (it) Regolatore di pressione per gas operante pneumaticamente.
ATE57526T1 (de) P-acylaminobenzamide.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
NO981707L (no) Xylanase, oligonukleotidsekvens som koder for xylanase og anvendelse derav
FR2603784A1 (fr) Meuble de relaxation multi-positions
IT8947610A0 (it) Agente e procedimento per la concia del cuoio